Ticker brief
RARE
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
18
authors 14d
6
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-01 · now +0.35 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OMillionaires | C | -1.10 | 8 | +0.37 |
| @semodough | C | -0.75 | 5 | +0.37 |
| @OptionsFlowBoss | C | · | 2 | +0.22 |
| @MikeJTrades | C | · | 1 | +0.35 |
| @fundmyfund | B | -2.01 | 1 | +0.40 |
| @Brad_E_Schulz | C | · | 1 | +0.20 |
Recent signals18of 18 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @semodough | +0.35 | Says OI traction with FDA would be upside surprise for RARE, though analysts largely ignore it. | · | tweet ↗ |
| 2026-06-30 | @OMillionaires | +0.50 | Afternoon update reports large percentage gains. | · | tweet ↗ |
| 2026-06-30 | @OMillionaires | +0.35 | RARE gap filled, next implied. | · | tweet ↗ |
| 2026-06-30 | @OMillionaires | +0.35 | Bags comment implies bullish excitement on RARE. | · | tweet ↗ |
| 2026-06-30 | @OMillionaires | +0.45 | RARE filling gaps with bullish money-bag language. | · | tweet ↗ |
| 2026-06-30 | @Brad_E_Schulz | +0.20 | Midday sector performance overview with bio/pharm and other categories plus percent gainers. | · | tweet ↗ |
| 2026-06-30 | @fundmyfund | +0.40 | Says many biotech charts including RARE are working in similar setups. | · | tweet ↗ |
| 2026-06-30 | @semodough | +0.50 | Goldman notes Ph3 GTX-102 data in 2H could translate from Ph1/2 and support filing. | · | tweet ↗ |
| 2026-06-30 | @semodough | +0.35 | Management discusses FY27 GAAP profitability aided by gene therapy launches and PRVs. | · | tweet ↗ |
| 2026-06-30 | @OMillionaires | +0.35 | Says RARE tastes better now, implying bullish satisfaction. | · | tweet ↗ |
| 2026-06-29 | @OMillionaires | +0.20 | Says RARE is on a gap-filling mission. | · | tweet ↗ |
| 2026-06-28 | @MikeJTrades | +0.35 | stay long RARE though overbought — System says stay long; author notes nice run, overbought, but weekly/monthly charts still rising. | · | tweet ↗ |
| 2026-06-26 | @OptionsFlowBoss | +0.00 | Mentions OI changes for RARE without direction. | · | tweet ↗ |
| 2026-06-25 | @OptionsFlowBoss | +0.45 | Reports $425K call buyer in RARE. | · | tweet ↗ |
| 2026-06-25 | @OMillionaires | +0.45 | Says RARE has gaps to fill at $33.90 then $39.70. | · | tweet ↗ |
| 2026-06-25 | @OMillionaires | +0.35 | Says RARE is heating up, but limited detail. | · | tweet ↗ |
| 2026-06-23 | @semodough | +0.20 | Morgan Stanley list of first-in-class 2026 biotech catalysts includes ABVX, CLDX and RARE. | · | tweet ↗ |
| 2026-06-22 | @semodough | +0.45 | RBC KOL left author incrementally more positive on RARE ahead of pivotal data, but notes 50/50 Phase III risk. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.